Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Chinook Therapeutics

12/08/2021 23:01

* Chinook Therapeutics Inc  KDNY.OQ  reported a quarterly
adjusted loss of $1.14​​ per share for the quarter ended in
June. The mean expectation of six analysts for the quarter was
for a loss of 78 cents per share.
* Revenue fell 99.4% to $34.00 thousand from a year ago; 
analysts expected $41.67 thousand. 
* Chinook Therapeutics Inc's reported EPS for the quarter was a
loss of 97 cents​.
* The mean earnings estimate of analysts had fallen by
about 1.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Chinook Therapeutics Inc shares had fallen by 14.0% this
quarter and lost 23.4% so far this year.
* The company reported a quarterly loss of $42.57 million.
* Wall Street's median 12-month price target for Chinook
Therapeutics Inc is $31.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 10:01 p.m.  ​All
figures in US dollars unless otherwise stated